Harvey E. Behrend

Array ( [id] => 4132518 [patent_doc_number] => 06034112 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Use of flupirtine the prophylaxis and therapy of diseases associated with an impairment of the hematopoetic cell system' [patent_app_type] => 1 [patent_app_number] => 9/061099 [patent_app_country] => US [patent_app_date] => 1998-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 2979 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034112.pdf [firstpage_image] =>[orig_patent_app_number] => 061099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1551203 [patent_doc_number] => 06399654 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Biflavanoids and derivatives thereof as antiviral agents' [patent_app_type] => B1 [patent_app_number] => 09/060839 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23856 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399654.pdf [firstpage_image] =>[orig_patent_app_number] => 09060839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550085 [patent_doc_number] => 06346529 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Antiviral therapy using thiazine dyes' [patent_app_type] => B1 [patent_app_number] => 09/060670 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6718 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346529.pdf [firstpage_image] =>[orig_patent_app_number] => 09060670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1270739 [patent_doc_number] => 06653297 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Control of selective estrogen receptor modulators' [patent_app_type] => B1 [patent_app_number] => 09/059476 [patent_app_country] => US [patent_app_date] => 1998-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2519 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653297.pdf [firstpage_image] =>[orig_patent_app_number] => 09059476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533144 [patent_doc_number] => 06410546 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Use of MKC-442 in combination with other antiviral agents' [patent_app_type] => B1 [patent_app_number] => 09/056548 [patent_app_country] => US [patent_app_date] => 1998-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7976 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410546.pdf [firstpage_image] =>[orig_patent_app_number] => 09056548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272686 [patent_doc_number] => 06245813 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Use of ubenimex and the pharmaceutical composition containing it for treating virus hepatitis' [patent_app_type] => 1 [patent_app_number] => 8/973958 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 1 [patent_no_of_words] => 3679 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245813.pdf [firstpage_image] =>[orig_patent_app_number] => 973958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4347040 [patent_doc_number] => 06284800 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Methods and compositions for treatment of asthma' [patent_app_type] => 1 [patent_app_number] => 9/042344 [patent_app_country] => US [patent_app_date] => 1998-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 5745 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284800.pdf [firstpage_image] =>[orig_patent_app_number] => 042344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278724 [patent_doc_number] => 06645961 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Dry granulation formulation for an HIV protease inhibitor' [patent_app_type] => B1 [patent_app_number] => 09/045885 [patent_app_country] => US [patent_app_date] => 1998-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3309 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645961.pdf [firstpage_image] =>[orig_patent_app_number] => 09045885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6934724 [patent_doc_number] => 20010056068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-27 [patent_title] => 'METHOD OF TREATMENT AND PREVENTION OF NITRIC OXIDE DEFICIENCY-RELATED DISORDERS WITH CITRULLINE AND CITRULLINE DERIVATIVES' [patent_app_type] => new [patent_app_number] => 09/034351 [patent_app_country] => US [patent_app_date] => 1998-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11680 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20010056068.pdf [firstpage_image] =>[orig_patent_app_number] => 09034351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4175348 [patent_doc_number] => 06083985 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Medicinal composition' [patent_app_type] => 1 [patent_app_number] => 9/000495 [patent_app_country] => US [patent_app_date] => 1998-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13738 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083985.pdf [firstpage_image] =>[orig_patent_app_number] => 000495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220827 [patent_doc_number] => 06040346 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Use of L-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs' [patent_app_type] => 1 [patent_app_number] => 9/000202 [patent_app_country] => US [patent_app_date] => 1998-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1754 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040346.pdf [firstpage_image] =>[orig_patent_app_number] => 000202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406890 [patent_doc_number] => 06271254 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Pharmaceutical compositions containing R-.alpha.-lipoic acid or S-.alpha.-lipoic acid as active ingredient' [patent_app_type] => 1 [patent_app_number] => 9/017409 [patent_app_country] => US [patent_app_date] => 1998-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6315 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271254.pdf [firstpage_image] =>[orig_patent_app_number] => 017409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4208678 [patent_doc_number] => 06028104 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Use of peroxygen compounds in the control of hairy wart disease' [patent_app_type] => 1 [patent_app_number] => 9/013560 [patent_app_country] => US [patent_app_date] => 1998-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4131 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028104.pdf [firstpage_image] =>[orig_patent_app_number] => 013560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305038 [patent_doc_number] => 06187803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Drug preparation for oral administration' [patent_app_type] => 1 [patent_app_number] => 9/013202 [patent_app_country] => US [patent_app_date] => 1998-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3116 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187803.pdf [firstpage_image] =>[orig_patent_app_number] => 013202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4420822 [patent_doc_number] => 06177441 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Treating red blood cell solutions with anti-viral agents' [patent_app_type] => 1 [patent_app_number] => 9/012702 [patent_app_country] => US [patent_app_date] => 1998-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20671 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177441.pdf [firstpage_image] =>[orig_patent_app_number] => 012702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154323 [patent_doc_number] => 06124319 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => '3,3-disubstituted piperidines as modulators of chemokine receptor activity' [patent_app_type] => 1 [patent_app_number] => 9/009488 [patent_app_country] => US [patent_app_date] => 1998-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16442 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 996 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124319.pdf [firstpage_image] =>[orig_patent_app_number] => 009488 [rel_patent_id] =>[rel_patent_doc_number] =>)